Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Live Oak Bancshares
LOB
$1.85B
| $6.32M | 0.01% |
+265,048
| New | +$6.4M |
|
|
DESP
1627
DELISTED
Despegar.com
DESP
| $6.31M | 0.01% |
229,737
-133,456
| -37% | -$3.83M |
|
1628
iShares MSCI Taiwan ETF
EWT
$11.6B
| $6.31M | 0.01% |
174,203
+73,643
| +73% | +$2.73M |
|
1629
Thermo Fisher Scientific
TMO
$234B
| $6.29M | 0.01% |
33,100
-383,584
| -92% | -$73.5M |
|
1630
New Mountain Finance
NMFC
$714M
| $6.28M | 0.01% |
463,360
+105,629
| +30% | +$1.49M |
|
|
SHYF
1631
DELISTED
The Shyft Group
SHYF
| $6.27M | 0.01% |
398,333
-119,810
| -23% | -$1.82M |
|
1632
Verisk Analytics
VRSK
$24.4B
| $6.21M | 0.01% |
64,723
-216,527
| -77% | -$19.6M |
|
1633
The Bancorp
TBBK
$2.73B
| $6.21M | 0.01% |
628,144
-113,124
| -15% | -$1.04M |
|
1634
Pitney Bowes
PBI
$2.35B
| $6.18M | 0.01% |
553,176
+188,101
| +52% | +$2.22M |
|
1635
iShares National Muni Bond ETF
MUB
$45.6B
| $6.15M | 0.01% |
55,555
+46,087
| +487% | +$5.1M |
|
1636
Ezcorp Inc
EZPW
$2.11B
| $6.15M | 0.01% |
504,103
-76,591
| -13% | -$836K |
|
1637
Signet Jewelers
SIG
$3.28B
| $6.14M | 0.01% |
108,665
-104,392
| -49% | -$6.38M |
|
1638
Silicon Laboratories
SLAB
$7.29B
| $6.12M | 0.01% |
+69,338
| New | +$6.23M |
|
1639
Coherus Oncology
CHRS
$210M
| $6.12M | 0.01% |
695,286
+623,248
| +865% | +$6.67M |
|
1640
iShares MSCI EAFE ETF
EFA
$80.1B
| $6.06M | 0.01% |
86,221
-84,253
| -49% | -$5.86M |
|
1641
Valmont Industries
VMI
$9.17B
| $6.05M | 0.01% |
36,480
-102,957
| -74% | -$16.7M |
|
1642
Assembly Biosciences
ASMB
$721M
| $6.05M | 0.01% |
11,139
+2,600
| +30% | +$1.18M |
|
1643
Old National Bancorp
ONB
$9.89B
| $6.04M | 0.01% |
346,121
+58,835
| +20% | +$1.06M |
|
1644
CALL
Zimmer Biomet
ZBH
$19.2B
| $6.03M | 0.01% |
51,500
-30,900
| -38% | -$3.49M |
|
1645
Chubb
CB
$133B
| $6.03M | 0.01% |
41,277
+37,810
| +1,091% | +$5.65M |
|
1646
ASE Group
ASX
$96.3B
| $6.03M | 0.01% |
930,189
-1,581,347
| -63% | -$10M |
|
1647
Campbell Soup
CPB
$6.96B
| $6.03M | 0.01% |
125,265
-576,731
| -82% | -$27.4M |
|
|
RFP
1648
DELISTED
Resolute Forest Products Inc.
RFP
| $6.02M | 0.01% |
544,627
+475,561
| +689% | +$3.85M |
|
1649
Cohu
COHU
$2.39B
| $6.01M | 0.01% |
274,001
-93,756
| -25% | -$2.24M |
|
|
CDK
1650
DELISTED
CDK Global, Inc.
CDK
| $6.01M | 0.01% |
84,280
-263,861
| -76% | -$17.7M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.